Listing 1 - 5 of 5 |
Sort by
|
Choose an application
The brain functions within an internal environment that is determined and controlled by morphological structures and cellular mechanisms present at interfaces between the brain and the rest of the body. In vertebrates these interfaces are across cerebral blood vessels (blood-brain barrier) choroid plexuses (blood-cerebrospinal fluid barrier) and pia-arachnoid. There is a CSF-brain barrier in the neuroepithelium lining the ventricular system that is only present in embryos. There is now substantial evidence that many brain barrier mechanisms develop early and that in some cases they are functionally more active and even more specialized compared to adult barriers. Therefore barriers in developing brain should be viewed as adapted appropriately for the growing brain and not, as is still widely believed, immature. Considerable advances in our understanding of these barrier mechanisms have come from studies of the developing brain and invertebrates. A striking aspect, to be highlighted in this special edition, is that many of the molecular mechanisms in these very diverse species are similar despite differences in the cellular composition of the interfaces. This Frontiers Topic comprises articles in three sections: Original studies, Reviews and Myths & Misconceptions. Original articles provide new information on molecular and cellular barrier mechanisms in developing brains of primates, including human embryos (Brøchner et al., Ek et al., Errede et al.), rodents (Bauer et al., Liddelow, Strazielle & Ghersi-Egea, Saunders et al., Whish et al.), chick (Bueno et al.) and zebrafish (Henson et al.) as well as studies in drosophila (Hindle & Bainton, De Salvo et al., Limmer et al.). The Reviews section includes evolutionary perspectives of the blood-brain and blood-CSF barriers (Bueno et al., Bill & Korzh). There are also detailed reviews of the current state of understanding of different interfaces and their functional mechanisms in developing brain (Bauer et al., Strazielle & Gjersi-Egea, Liddelow, Richardson et al., Errede et al., Henson et al., Brøchner et al.) and in invertebrates (Hindle & Bainton, De Salvo et al., Limmer et al). Different aspects of the relationship between properties of the internal environment of the brain and its development are discussed. (Stolp & Molnar, Johansson, Prasongchean et al.). A neglected area, namely barriers over the surface of the brain during development is also covered (Brøchner et al.). Clinically related perspectives on barrier disruption in neonatal stroke are provided by Kratzer et al. and other aspects of dysfunction by Morretti et al. and by Palmeta et al. on the continuing problem of bilirubin toxicity. Progress in this field is hampered by many prevailing myths about barrier function, combined with methodologies that are not always appropriately selected or interpreted. These are covered in the Misconceptions, Myths and Methods section, including historical aspects and discussion of the paracellular pathway, a central dogma of epithelial and endothelial biology (Saunders et al.) and a review of markers used to define brain barrier integrity in development and in pathological conditions (Saunders et al.). Use of inappropriate markers has caused considerable confusion and unreliable interpretation in many published studies. Torbett et al. deal with the complexities of the new field of applying proteomics to understanding blood-brain barrier properties as do Huntley at al. with respect to applying modern high throughput gene expression methods (Huntley et al.). The Editorial summarizes the contributions from all authors. This includes mention of some the main unanswered but answerable questions in the field and what the impediments to progress may be.
zebra fish --- development --- Influx mechanisms --- Tight Junctions --- Drosophila --- Efflux mechanisms --- blood-CSF barrier --- Choroid Plexus --- Blood-Brain Barrier
Choose an application
Over 70% of the Earth’s surface is covered by oceans and seas, which are massively complex and consist of diverse assemblages of life forms. Marine bacteria, fungi, and other microorganisms develop unique metabolic and physiological capabilities that enable them to survive in extreme habitats and to produce compounds that might not be produced by their terrestrial counterparts. In the last few decades, the systematic investigations of marine/marine-derived microorganisms as sources of novel biologically active agents has exponentially increased. This Special Issue will focus on aspects relating to new bioactive metabolites from marine microorganisms including the isolation, taxonomy, and/or dereplication of microorganisms and the corresponding isolation, structure elucidation, biosynthesis, and/or biological activities of the new compounds. Comprehensive topical review articles relating to marine metabolites will also be considered.
co-culture --- marine microbes --- natural products --- structural diversity --- biological activities --- food allergy --- deep-sea-derived viridicatol --- X-ray single crystal --- intestinal barrier --- mast cell --- calcium influx --- Chlorella --- enzymes --- lipases --- molecular modeling --- sulfated polysaccharides --- antiviral --- SARS-CoV-2 --- docking --- molecular dynamic simulations --- sea cucumber --- bioactivity --- diversity --- microorganism --- polyketides --- alkaloids --- marine-derived fungus --- Penicillium sp. --- indole-diterpenoids --- cytotoxicity --- antibacterial activity --- Leizhou Peninsula --- mangrove soil --- actinomycetia --- antimicrobial activity --- secondary metabolites --- dereplication --- metabolomics tools --- trioxacarcins --- mansouramycins --- isoquinolinequinones --- marine-derived Streptomyces sp. --- n/a
Choose an application
The rapid increasing of concentrations of anthropologically generated greenhouse gases (primarily CO2) in the atmosphere is responsible for global warming and ocean acidification. The International Panel on Climate Change (IPCC) indicates that carbon capture and storage (CCS) techniques are a necessary measure to reduce greenhouse gas emissions in the short-to-medium term. One of the technological solutions is the long-term storage of CO2 in appropriate geological formations, such as deep saline formations and depleted oil and gas reservoirs. Promising alternative options that guarantee the permanent capture of CO2, although on a smaller scale, are the in-situ and ex-situ fixation of CO2 in the form of inorganic carbonates via the carbonation of mafic and ultramafic rocks and of Mg/Ca-rich fly ash, iron and steel slags, cement waste, and mine tailings. According to this general framework, this Special Issue collects articles covering various aspects of recent scientific advances in the geological and mineralogical sequestration of CO2. In particular, it includes the assessment of the storage potential of candidate injection sites in Croatia, Greece, and Norway; numerical modelling of geochemical–mineralogical reactions and CO2 flow; studies of natural analogues providing information on the processes and the physical–chemical conditions characterizing serpentinite carbonation; and experimental investigations to better understand the effectiveness and mechanisms of geological and mineralogical CO2 sequestration.
CO2 reservoir rock --- CO2 sealing capacity --- CO2 sequestration --- CO2 storage capacity --- CO2 storage ratio --- supercritical CO2 --- CO2 geological storage --- depleted gas fields --- deep saline aquifers --- Adriatic offshore --- Croatia --- CO2 geological sequestration --- unconsolidated sediments --- gas hydrates --- suitable methodology for mineral carbonation --- construction and demolition waste --- basalts --- carbonation --- CO2 storage --- hydrochemistry --- regional heat flow --- CO2 leakage --- cement --- well integrity --- leakage remediation --- TOUGHREACT --- reactive transport modelling --- CCS --- mineralization --- carbonatization --- mineral trapping --- mineral sequestration --- Johansen Formation --- North Sea --- sedimentary facies --- serpentinite --- X-ray diffraction --- rietveld refinement --- magnesium leaching --- thermal activation --- meta-serpentine --- heat activation optimization --- CO2 mineral sequestration --- hydromagnesite --- kerolite --- Cu mine --- Montecastelli --- underground microclimate --- replacement process --- low temperature carbonate precipitation --- Secondary Ion Mass Spectrometer --- seawater influx --- hydrothermal circulation --- ophicalcite --- n/a
Choose an application
This book serves to highlight the pharmacokinetics/drug–drug interactions and mechanistic understanding in relation to the drug-metabolizing enzymes and drug transporters.This book presents a series of drug metabolism and transport mechanisms that govern the pharmacokinetic features of therapeutic drugs as well as natural herbal medicines. It also covers the pharmacokinetic interactions caused by inhibiting or inducing the metabolic or transport activities under disease states or the coadministration of potential inhibitors. It also deals with microenvironmental pharmacokinetic profiles as well as population pharmacokinetics, which gives new insights regarding the pharmacokinetic features with regard to drug metabolism and transporters.
tofacitinib --- dose-dependent pharmacokinetics --- hepatic and intestinal first-pass effect --- rats --- catalposide --- in vitro human metabolism --- UDP-glucuronosyltransferase --- sulfotransferase --- carboxylesterase --- celecoxib --- drug–drug interaction --- fluorescence --- HPLC --- metabolism --- repaglinide --- HSG4112 --- anti-obesity agent --- stereoselectivity --- pharmacokinetics --- compound K --- protopanaxadiol (PPD) --- biliary excretion --- intestinal metabolism --- Carthamus tinctorius extract --- notoginseng total saponins --- comparative pharmacokinetic study --- large volume direct injection --- compatibility mechanism --- mertansine --- human hepatocytes --- cytochrome P450 --- UDP-glucuronosyltransferases --- sodium-glucose cotransporter 2 (SGLT2) inhibitors --- DWP16001 --- kidney distribution --- inhibition mode --- diabetes --- transporter-enzyme interplay --- influx transporter --- efflux transporter --- physiologically based pharmacokinetic model --- cytochrome P450 enzymes --- tiropramide --- healthy Korean subjects --- modeling --- population pharmacokinetic --- quercetin --- breast cancer resistance protein --- inhibitor --- prazosin --- sulfasalazine --- kinetic analysis --- food–drug interactions --- Caco-2 --- EpiIntestinal --- first-pass --- P-gp --- BCRP --- drug transporter --- CYP3A4 --- oral availability --- automatization --- drug absorption --- drug dosing --- head-and-neck cancer --- real-time measurements --- taxanes --- tissue engineering --- UHPLC-MS/MS --- metformin --- verapamil --- drug interaction --- organic cation transporter 2 --- renal excretion --- acute renal failure --- gentamicin --- cisplatin --- hepatic CYP3A1(23) --- creatinine clearance --- renal clearance --- nonrenal clearance
Choose an application
There are various malignant tumors in the head and neck area, including oral cavity, pharynx, sinonasal cavity, and salivary glands. Squamous cell carcinoma is the most common cancer among head and neck cancers. In salivary glands, there are many types of malignancies that can develop, such as malignant lymphoma, adenoid cystic carcinoma, adenocarcinoma, and mesenchymal tumors. In a clinical setting, imaging, such as computed tomography (CT) and magnetic resonance imaging (MRI), is very important in terms of the prediction of the histological type and the evaluation of the extent of invasion of adjacent structures. In basic research, there are few animal models in head and neck malignancies. In this Special Issue, we broadly discuss the basic and clinical research in head and neck malignancies.
BDNF --- Brain-Derived Neurotrophic Factor --- navigation --- spatial processing --- trauma --- trauma processing --- Post-Traumatic Stress Disorder --- PSTD --- allocentric --- hippocampus --- sinonasal tract --- malignant tumor --- CT --- MRI --- neuropsychiatric presentation of encephalitis --- paraneoplastic encephalitis --- autoimmune encephalitis --- infectious encephalitis --- diffuse large B-cell lymphoma --- canaloplasty --- non-perforating surgical procedures --- corticosteroid-induced glaucoma --- Schlemm’s canal --- neck mass --- diffusion-weighted MRI --- apparent diffusion coefficient --- procalcitonin --- bacterial meningitis --- viral meningitis --- antibiotic therapy --- biomarker --- differential diagnosis --- human papillomavirus --- human cancer --- head and neck --- reduction therapy --- head and neck squamous cell carcinoma (HNSCC) --- neutrophil-to-lymphocyte ratio (NLR) --- myeloid-derived suppressor cells (MDSC) --- aldehyde dehydrogenase 1 (ALDH1) --- prognosis --- prodigiosin --- doxorubicin --- priming --- influx --- autophagy --- cervical --- cellulitis --- abscess --- deep neck infection --- diabetes mellitus --- MAP1LC3B --- SQSTM1 --- subsites --- tumorigenesis --- oral cancer --- Nox4 --- oral tongue cancer --- squamous cell carcinoma --- surgery --- head and neck squamous cell carcinoma --- HPV --- 11q13 --- gene amplification --- immunohistochemistry --- head and neck cancer --- radiotherapy --- neutrophil/lymphocyte ratio --- survival --- ZFAND4 --- ANUBL1 --- oral squamous cell carcinoma --- nucleotide excision repair --- genetic polymorphism --- concurrent chemoradiotherapy --- HNSCC --- MIF --- 4-IPP --- metabolism --- annexin A9 --- annexin A10 --- differentiation grade --- NGS
Listing 1 - 5 of 5 |
Sort by
|